Supplement for preventing thyroid overactivity
Part of Hormones & metabolism clinical trials.
This trial tests whether a supplement with zinc, selenium, and L-tyrosine can help prevent an overactive thyroid condition. It's for people with a specific gene variation and high thyroid antibodies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old
- You are not pregnant or breastfeeding
- You have no known allergy to zinc, selenium, or L-tyrosine
- You have not been diagnosed with a thyroid disease
- You have a specific gene variation called SEPP1 (r25191G/A) and high thyroid antibody levels (TPOAb > 300 IU/mL)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way of providing thyroid hormone therapy for people who still feel tired and other bothersome symptoms despite currently taking a standard thyroid pill (levothyroxine). It combines two types of thyroid hormone (T4 and T3) to see if it better relieves symptoms than the usual treatment.
This trial tests a new porcine (pig) thyroid hormone replacement tablet for people with primary hypothyroidism (underactive thyroid). It aims to see if this treatment is safe and effective compared to current levothyroxine therapy.
This trial tests whether taking myo-inositol and selenium supplements can help reduce the risk of thyroid cancer in people with thyroid nodules that are considered 'indeterminate' (TIR3a). The goal is to see if these supplements can prevent the nodules from becoming cancerous.
This study tests a new approach for people with hypothyroidism who are already taking levothyroxine. You may be able to join if you are on a certain dose and do not have other health conditions that could affect the results.
This trial tests whether taking thyroid hormone (levothyroxine) can help prevent another pregnancy loss in women who have had multiple losses and have a low free T4 level with normal TSH. It aims to see if this treatment improves pregnancy outcomes.
This trial is for people who may have a problem with how their body responds to thyroid hormone. It aims to better understand, diagnose, and monitor these conditions to improve care.
Hear when a new Thyrotoxicosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.